Changlin Yang

1.4k total citations
46 papers, 660 citations indexed

About

Changlin Yang is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Changlin Yang has authored 46 papers receiving a total of 660 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 16 papers in Molecular Biology and 15 papers in Immunology. Recurrent topics in Changlin Yang's work include CAR-T cell therapy research (13 papers), Immunotherapy and Immune Responses (11 papers) and Glioma Diagnosis and Treatment (10 papers). Changlin Yang is often cited by papers focused on CAR-T cell therapy research (13 papers), Immunotherapy and Immune Responses (11 papers) and Glioma Diagnosis and Treatment (10 papers). Changlin Yang collaborates with scholars based in United States, China and Botswana. Changlin Yang's co-authors include Duane A. Mitchell, Jianping Huang, Elias Sayour, Maryam Rahman, Aida Karachi, Paul Kubilis, Catherine Flores, Yu Long, Linchun Jin and Farhad Dastmalchi and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Changlin Yang

37 papers receiving 656 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Changlin Yang United States 13 295 263 247 229 99 46 660
Farhad Dastmalchi United States 13 216 0.7× 169 0.6× 215 0.9× 191 0.8× 93 0.9× 22 551
Brandyn Castro United States 10 251 0.9× 157 0.6× 177 0.7× 224 1.0× 107 1.1× 21 622
Daniel Wilkinson United States 13 377 1.3× 290 1.1× 154 0.6× 168 0.7× 62 0.6× 21 699
Selena Lorrey United States 9 320 1.1× 373 1.4× 159 0.6× 230 1.0× 62 0.6× 17 718
Caijun Zha China 10 243 0.8× 96 0.4× 138 0.6× 290 1.3× 133 1.3× 11 595
Tina Verschuere Belgium 17 641 2.2× 404 1.5× 273 1.1× 307 1.3× 82 0.8× 21 1.0k
Shihong Zhao China 15 263 0.9× 123 0.5× 135 0.5× 447 2.0× 235 2.4× 35 897
Sonja Schelhaas Germany 14 141 0.5× 231 0.9× 80 0.3× 359 1.6× 110 1.1× 27 718
Zineb Belcaid United States 13 405 1.4× 472 1.8× 310 1.3× 148 0.6× 52 0.5× 24 744
Irina Fernandez United States 9 245 0.8× 194 0.7× 101 0.4× 180 0.8× 47 0.5× 9 478

Countries citing papers authored by Changlin Yang

Since Specialization
Citations

This map shows the geographic impact of Changlin Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changlin Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changlin Yang more than expected).

Fields of papers citing papers by Changlin Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Changlin Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changlin Yang. The network helps show where Changlin Yang may publish in the future.

Co-authorship network of co-authors of Changlin Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Changlin Yang. A scholar is included among the top collaborators of Changlin Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Changlin Yang. Changlin Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Changlin, Wei Chen, Xinxin Wang, et al.. (2025). Cell-Free DNA Comprises the Strand-Specific Characteristic Associated with Transcription and Methylation. Clinical Chemistry. 71(9). 980–992.
2.
Yang, Changlin, et al.. (2024). One-Step laser induced molybdenum carbide/graphene hybrid electrode for supercapacitor. Chemical Engineering Journal. 499. 156519–156519. 2 indexed citations
3.
Yang, Changlin, Christina A. Von Roemeling, Lan Hoang-Minh, et al.. (2024). mRNA-based precision targeting of neoantigens and tumor-associated antigens in malignant brain tumors. Genome Medicine. 16(1). 17–17. 28 indexed citations
4.
Roemeling, Christina A. Von, Changlin Yang, Bently P. Doonan, et al.. (2024). Adeno-associated virus delivered CXCL9 sensitizes glioblastoma to anti-PD-1 immune checkpoint blockade. Nature Communications. 15(1). 5871–5871. 5 indexed citations
5.
Yang, Changlin, Jesse Kresak, Diana Feier, et al.. (2024). KR158 Spheres Harboring Slow-Cycling Cells Recapitulate High-Grade Glioma Features in an Immunocompetent System. Cells. 13(11). 938–938. 1 indexed citations
6.
Ogando‐Rivas, Elizabeth, Paul Castillo, Changlin Yang, et al.. (2024). Expanded specific T cells to hypomutated regions of the SARS-CoV-2 using mRNA electroporated antigen-presenting cells. Molecular Therapy — Methods & Clinical Development. 32(1). 101192–101192.
7.
Dean, Joseph, Changlin Yang, Connor Francis, et al.. (2023). Immunotherapy reverses glioma-driven dysfunction of immune system homeostasis. Journal for ImmunoTherapy of Cancer. 11(2). e004805–e004805. 3 indexed citations
8.
Sun, Zhiyan, Changlin Yang, Lijie Huang, et al.. (2023). circRNADisease v2.0: an updated resource for high-quality experimentally supported circRNA-disease associations. Nucleic Acids Research. 52(D1). D1193–D1200. 19 indexed citations
9.
Sun, Si, Changlin Yang, Kuanyu Wang, et al.. (2023). Molecular and clinical characterization of PTRF in glioma via 1,022 samples. BMC Cancer. 23(1). 551–551.
10.
Yang, Changlin, Andria Doty, Shu Wang, et al.. (2022). Slow-Cycling Cells in Glioblastoma: A Specific Population in the Cellular Mosaic of Cancer Stem Cells. Cancers. 14(5). 1126–1126. 7 indexed citations
11.
Zhao, Zheng, Kenan Zhang, Zhiyan Sun, et al.. (2022). WES data from 286 diffuse gliomas under the 2021 WHO Classification of Tumors of the Central Nervous System. Scientific Data. 9(1). 692–692. 10 indexed citations
12.
Meng, Fanlin, Kenan Zhang, Changlin Yang, et al.. (2022). Prognostic Pathways Guide Drug Indications in Pan-Cancers. Frontiers in Oncology. 12. 849552–849552. 1 indexed citations
13.
Karachi, Aida, Farhad Dastmalchi, Jianping Huang, et al.. (2021). Optimizing T Cell-Based Therapy for Glioblastoma. Frontiers in Immunology. 12. 705580–705580. 13 indexed citations
14.
Yu, Zhihao, Changlin Yang, Xuesong Bai, et al.. (2021). Risk factors for cholesterol polyp formation in the gallbladder are closely related to lipid metabolism. Lipids in Health and Disease. 20(1). 26–26. 10 indexed citations
15.
Dyson, Kyle, Connor Francis, Changlin Yang, et al.. (2020). Immune Escape After Adoptive T-cell Therapy for Malignant Gliomas. Clinical Cancer Research. 26(21). 5689–5700. 31 indexed citations
16.
Bai, Xuesong, Yao Feng, Tao Wang, et al.. (2020). Impact of metabolic syndrome on short-term outcome of carotid revascularization: a large sample size study in Chinese population. Chinese Medical Journal. 133(22). 2688–2695. 3 indexed citations
17.
Dastmalchi, Farhad, Aida Karachi, Changlin Yang, et al.. (2019). Sarcosine promotes trafficking of dendritic cells and improves efficacy of anti-tumor dendritic cell vaccines via CXC chemokine family signaling. Journal for ImmunoTherapy of Cancer. 7(1). 321–321. 30 indexed citations
18.
Rahman, Maryam, Jesse Kresak, Changlin Yang, et al.. (2018). Analysis of immunobiologic markers in primary and recurrent glioblastoma. Journal of Neuro-Oncology. 137(2). 249–257. 33 indexed citations
19.
Flores, Catherine, Changlin Yang, Jeffrey Drake, et al.. (2018). IMMU-04. RNA-ENGINEERED T CELLS AS A BIOLOGICAL CARRIER TO DELIVER MACROMOLECULES TO INTRACRANIAL TUMORS. Neuro-Oncology. 20(suppl_2). i99–i99. 1 indexed citations
20.
Pham, Christina, Catherine Flores, Changlin Yang, et al.. (2015). Differential Immune Microenvironments and Response to Immune Checkpoint Blockade among Molecular Subtypes of Murine Medulloblastoma. Clinical Cancer Research. 22(3). 582–595. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Farhad Dastmalchi Breakdown of academic impact, for papers by Brandyn Castro Breakdown of academic impact, for papers by Daniel Wilkinson Breakdown of academic impact, for papers by Selena Lorrey Breakdown of academic impact, for papers by Caijun Zha Breakdown of academic impact, for papers by Tina Verschuere Breakdown of academic impact, for papers by Shihong Zhao Breakdown of academic impact, for papers by Sonja Schelhaas Breakdown of academic impact, for papers by Zineb Belcaid Breakdown of academic impact, for papers by Irina Fernandez
Rankless by CCL
2026